![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Press Release: Execution of a share buyback agreement for up to €2 billion Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025, Sanofi...
Communiqué de presse : Sanofi annonce la signature d’un mandat de rachat d'actions pour un montant maximum de 2 milliards d’euros Sanofi annonce la signature d’un mandat de rachat d'actions...
Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal Sanofi annonce un rachat d'actions à L'Oréal Paris, le 3 février 2025. Sanofi annonce aujourd'hui l'acquisition de...
Press Release: Sanofi announces buy back of shares from L’Oréal Sanofi announces buy back of shares from L’Oréal Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its...
Communiqué de presse : Sarclisa est le premier anti-CD38 approuvé en Chine pour le traitement du myélome multiple nouvellement diagnostiqué des patients non éligibles à une greffe Sarclisa est le...
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Sarclisa is the first anti-CD38 treatment...
Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du BNPA des activités de 2024 dépassé. Fort rebond du BNPA des activités attendu en 2025 Sanofi: Croissance des ventes de...
Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II...
Sanofi: Information concerning the total number of voting rights and shares - December 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions